Skip to main content
. 2020 Aug 1;9(16):e015103. doi: 10.1161/JAHA.119.015103

Figure 3. Subgroup analyses of the change in BNP concentrations.

Figure 3

Data on the change in ratio of BNP concentrations from baseline to 12 weeks with each treatment according to subgroup are shown. ASCVD indicates atherosclerotic cardiovascular disease; BNP, B‐type natriuretic peptide; GFR, glomerular filtration rate; and HbA1c, hemoglobin A1c.